Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance of [14C]HRS-7535 in Healthy Adult Chinese Subjects
NCT06819488Phase 1Completed
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Feb 2025
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of HRS-7535 in type 2 diabetes mellitus (T2DM) and obesity, sponsored by Shandong Suncadia Medicine Co., Ltd. Primary endpoints: Time of Maximum Observed Concentration, Maximum Observed Concentration and 4 more. Started Feb 2025; status: completed.
02
Drugs
HRS-7535
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT06819488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06819488.